GH-Axis Peptides
CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, GHRP-2/6 and other growth-hormone-axis research peptides and blends.
CJC-1295 (no DAC)
Modified GRF 1-29 · GHRH analog
- CAS
- (see DAC-version distinction)
- Vial
- 2 mg–10 mg
MOQ on requestGet quote →
Ipamorelin
Ghrelin / GHSR pathway GH-release peptide
- CAS
- 170851-70-4
- Vial
- 2 mg–10 mg
MOQ on requestGet quote →
Sermorelin
GHRH 1-29 fragment
- CAS
- 86168-78-7
- Vial
- 2 mg–10 mg
MOQ on requestGet quote →
AOD9604
Modified HGH fragment 176–191 (anti-obesity drug candidate)
- CAS
- 221231-10-3
- Vial
- 2 mg–10 mg
MOQ on requestGet quote →
HGH Fragment 176-191
C-terminal fragment of human growth hormone (176–191)
- CAS
- 66004-57-7
- Vial
- 1 mg–15 mg
MOQ on requestGet quote →
CJC-1295 with DAC
Long-acting GHRH analog with Drug Affinity Complex
- CAS
- 863288-34-0
- Vial
- 2 mg · 5 mg
MOQ on requestGet quote →
GHRP-2
Growth-hormone-releasing peptide-2 · Pralmorelin
- CAS
- 158861-67-7
- Vial
- 5 mg · 10 mg
MOQ on requestGet quote →
GHRP-6
Growth-hormone-releasing peptide-6
- CAS
- 87616-84-0
- Vial
- 5 mg · 10 mg
MOQ on requestGet quote →
Tesamorelin
GHRH analog · approved for HIV-associated lipodystrophy
- CAS
- 218949-48-5
- Vial
- 2 mg–20 mg
MOQ on requestGet quote →
IGF-1 LR3
Long-Arg3 IGF-1 (long-acting IGF-1 analog)
- CAS
- 946870-92-4
- Vial
- 100 mcg–2 mg
MOQ on requestGet quote →
MGF (Mechano Growth Factor)
IGF-1 Ec splice-variant peptide
- CAS
- (verification pending — please confirm via COA)
- Vial
- 2 mg
MOQ on requestGet quote →